Literature DB >> 25563803

The anti-arrhythmic effect of chronic intermittent hypobaric hypoxia in rats with metabolic syndrome induced with fructose.

Jing-Jing Zhou1, Hui-Jie Ma, Yan Liu, Yue Guan, Leonid N Maslov, De-Pei Li, Yi Zhang.   

Abstract

This study investigated the anti-arrhythmic effects from chronic intermittent hypobaric hypoxia (CIHH) and the cellular mechanisms in rats with metabolic syndrome. Male Sprague-Dawley rats were randomly distributed among the control, fructose-fed (fed with 10% fructose in the drinking water to induce metabolic syndrome), CIHH (42 days of hypobaric hypoxia treatment simulating an altitude of 5000 m a.s.l.: PB = 404 mm Hg, PO2 = 84 mm Hg, 6 h per day), and the CIHH plus fructose (CIHH-F) groups. In anesthetized rats, the arrhythmia score was determined after 30 min of cardiac ischemia followed by 120 min of reperfusion. Action potentials (AP) were recorded from isolated ventricular papillary muscles. The arrhythmia score was much lower in CIHH-F rats than in the fructose-fed rats. Under basic conditions, AP duration (APD) was significantly shortened in fructose-fed rats, but obviously prolonged in CIHH rats compared with that of the control rats. During ischemia, the AP amplitude, the maximal rate of rise of phase 0, APD, and resting potential, were lower in the control, fructose-fed, and CIHH-F groups, but were not changed in the CIHH rats. The lower AP during ischemia did not recover after washout for the fructose-fed rats. In conclusion, CIHH protects the heart against ischemia-reperfusion induced arrhythmia in rats with metabolic syndrome. This effect of CIHH is possibly related to baseline prolongation of the AP and attenuation of AP reduction during ischemia-reperfusion.

Entities:  

Keywords:  action potential; chronic intermittent hypobaric hypoxia; hypoxie hypobare intermittente chronique; ischemia–reperfusion; metabolic syndrome; muscle papillaire; papillary muscle; potentiel d’action; syndrome métabolique, ischémie–reperfusion

Mesh:

Substances:

Year:  2014        PMID: 25563803     DOI: 10.1139/cjpp-2014-0343

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  5 in total

1.  Modulating cardiac conduction during metabolic ischemia with perfusate sodium and calcium in guinea pig hearts.

Authors:  Sharon A George; Gregory Hoeker; Patrick J Calhoun; Michael Entz; Tristan B Raisch; D Ryan King; Momina Khan; Chandra Baker; Robert G Gourdie; James W Smyth; Morten S Nielsen; Steven Poelzing
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

2.  Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.

Authors:  Eugenia B Manukhina; H Fred Downey; Xiangrong Shi; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

3.  Reparative effects of chronic intermittent hypobaric hypoxia pre‑treatment on intervertebral disc degeneration in rats.

Authors:  Shu-Ren Liu; Dong Ren; Hao-Tan Wu; Shuang-Quan Yao; Zhao-Hui Song; Lin-Dan Geng; Peng-Cheng Wang
Journal:  Mol Med Rep       Date:  2022-03-22       Impact factor: 2.952

4.  Enhancement of Glucose Metabolism via PGC-1α Participates in the Cardioprotection of Chronic Intermittent Hypobaric Hypoxia.

Authors:  Xuyi Li; Yan Liu; Huijie Ma; Yue Guan; Yue Cao; Yanming Tian; Yi Zhang
Journal:  Front Physiol       Date:  2016-06-08       Impact factor: 4.566

5.  Mechanisms of Cardiovascular Protection Associated with Intermittent Hypobaric Hypoxia Exposure in a Rat Model: Role of Oxidative Stress.

Authors:  Miguel Aguilar; Alejandro González-Candia; Jorge Rodríguez; Catalina Carrasco-Pozo; Daniel Cañas; Claudio García-Herrera; Emilio A Herrera; Rodrigo L Castillo
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.